Oliver M Colvin

Title: The Innovations of Oliver M. Colvin

Introduction

Oliver M. Colvin is an accomplished inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of pharmacogenomics, particularly in the evaluation of how individuals metabolize pharmaceuticals. His work has implications for personalized medicine and the optimization of chemotherapy treatments.

Latest Patents

Colvin holds a patent titled "Methods for evaluating the ability to metabolize pharmaceuticals." This patent discloses methods for detecting variant genes that have a polymorphism associated with reduced metabolism of specific substrates, including CYP3A4 and CYP3A5. The methods are designed to identify polymorphisms linked to reduced metabolism of chemotherapeutic agents, such as cyclophosphamide and BCNU. Additionally, the patent includes novel polymorphic nucleic acid molecules that are useful in these methods.

Career Highlights

Throughout his career, Colvin has worked with notable organizations, including Genaissance Pharmaceuticals, Inc. and Duke University. His experience in these institutions has allowed him to advance his research and contribute to the understanding of drug metabolism.

Collaborations

Colvin has collaborated with several professionals in his field, including Marco Guida and Jeff Hall. These collaborations have enriched his research and expanded the impact of his work.

Conclusion

Oliver M. Colvin's innovative work in pharmacogenomics and his patent on evaluating drug metabolism highlight his contributions to the field. His research continues to pave the way for advancements in personalized medicine and improved treatment outcomes.